Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by prophetoffactzon Nov 24, 2023 12:30pm
85 Views
Post# 35751729

Avenanthramide - the big vision:

Avenanthramide - the big vision:As the avenanthramide pill advances and data discovered, and the avenanthramide malted technology for neutraceutical applications advances, and the powder avenanthramide advances, and the wound healing studies, could CZO turn avenanthramide into a blockbuster drug from pill, to neutraceutical, to wound healing, etc.? Gilles vision was to transform avenanthramide into a pharma product. CZO has also investigated avenanthramide with its newer PGX carriers. Gilles has mentioned a potential treatment for exercise inflammation given results in humans to date at a much lower dose than the pill trial. The avenanthramide malted technology allows CZO to reach the neutraceutical market for the first time as in sport's bars, etc.  

CZO's exercise inflammation study:

With the increasing demand for physical activity to promote a healthier lifestyle among the general public, maintaining proper antioxidant defense during exercise and sports is an important issue for muscle health 


Finally, our present study indicated that chronic oat consumption not only ameliorated plasma inflammatory response to exercise stress, but also mitigated muscle damage as revealed by a lower plasma CK level (Fig. 2). Furthermore, pain sensation by the subjects, most likely related to DR-induced muscle damage, was reduced during post-supplementation trials especially among subjects treated with AVA-enriched diet (Fig. 9). These physiological data support the notion that besides the general benefits of oat consumption derived from various antioxidant and anti-hyperglycemic ingredients, long-term dietary supplementation of AVA may provide specific protection against detrimental impact of damaging muscular exertion.
Avenanthramide supplementation reduces eccentric exercise-induced inflammation in young men and women - PMC (nih.gov)
<< Previous
Bullboard Posts
Next >>